about
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision d...
Read More
19.56
1.38
(7.59%)
6.0M
XNAS Volume
High vol.+gain this week
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
Alumis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..